PSYG — Psyence Balance Sheet
0.000.00%
Last trade - 00:00- CA$1.31m
- CA$25.49m
Annual balance sheet for Psyence, fiscal year end - March 31st, CAD millions except per share, conversion factor applied.
2020 December 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Cash and Short Term Investments | 0.096 | 6.1 | 3.49 | 2.38 | 1.06 |
| Net Total Receivables | — | 0.182 | 0.142 | 0.245 | 0.237 |
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 0.125 | 6.32 | 3.8 | 2.78 | 1.79 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | — | 0.392 | 0.511 | 0.626 | 1.47 |
| Net Intangible Assets | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 0.125 | 6.73 | 4.35 | 4 | 3.27 |
| Accounts Payable | |||||
| Payable / Accrued | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 0.137 | 0.237 | 1.59 | 2.62 | 15.1 |
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Minority Interest | |||||
| Total Liabilities | 0.137 | 0.292 | 1.64 | 2.67 | 27.2 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | -0.012 | 6.44 | 2.71 | 1.33 | -23.9 |
| Total Liabilities & Shareholders' Equity | 0.125 | 6.73 | 4.35 | 4 | 3.27 |
| Total Common Shares Outstanding |